ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Connie Mack Joins Washington Office Of Shaw Pittman.

March 2, 2001